Morgan Stanley Stays Bearish On Fitbit After Apple Watch Unveil, Says Revenue Is The Real Concern

Apple Inc. AAPL's launch of the Series 4 Apple Watch, with features that include a built-in heart monitor, sent shares of rival smartwatch manufacturer Fitbit Inc FIT down by about 7 percent Wednesday.

The Analyst

Morgan Stanley analyst Yuuji Anderson maintained an Underweight rating on Fibit with a $4 price target.

The Thesis

Fitbit's  stock reaction to Apple's launch largely reflected concerns over the pace of software and sensor improvements in the Fitbit ecosystem, Anderson said in a Thursday note. (See the analyst's track record here.) 

The Apple Watch 4 has sensors and an app to detect atrial fibrillation — one of many health and wellness use cases Fitbit is also pursuing, the analyst said. 

Fitbit's newest products Versa, at $200, and Charge 3, at $150, address lower price points, Anderson said. 

Morgan Stanley's below-consensus estimates for Fitbit show concerns that the "health and fitness functionalities between the Versa and Charge 3 are not sufficiently differentiated to avoid cannibalization."

Aggregate demand will not sufficiently offset declines in legacy products exiting 2018, Anderson said. 

Continued revenue declines with lower-priced products will drag Fitbit shares down toward Morgan Stanley's price target, the analyst said.

The Price Action

Fitbit shares have lost about 3.2 percent year-to-date.

Related Links:

How The Tariff Threats Could Impact Smartwatches

This Day In Market History: Fitbit IPO

Photo courtesy of Fitbit. 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetReiterationAnalyst RatingsMorgan StanleyYuuji Anderson
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!